Molecule Name |
DB08889
|
DrugBank Groups |
Approved
|
Cluster No |
1008
|
Smiles |
O=C(NC(C(=O)C1(OC1)(C))CC(C)C)C(NC(=O)C(NC(=O)C(NC(=O)CN2(CCOCC2))CCC3(=CC=CC=C3))CC(C)C)CC4(=CC=CC=C4)
|
Download |
mol2, pdbqt
|
TPSA |
158,47
|
Non-H Atoms |
52
|
Non-C/H Atoms |
12
|
Metal-Atoms |
0
|
Electronegative Atoms |
12
|
Stereo Centers |
5
|
Rotatable Bonds |
20
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
2
|
Aromatic Atoms |
12
|
sp3-Atoms |
26
|
Symmetric atoms |
8
|
cLogS |
-4,57
|
MW |
719,921
|
cLogP |
2,513
|
HBA |
12
|
HBD |
4
|
Ro5 violations |
2
|
Druglikeness |
4,0173
|
DrugScore |
8,81611499645862E-02
|
Mutagenic |
high
|
Tumorigenic |
high
|
Reproductive Effective |
none
|
Irritant |
high
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,9039
|
Caco-2 Permeability 2 |
0,8873
|
Subcellular localization |
Lysosome
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,584
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,3859
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6381
|
Carcinogenicity (Three-class) |
Non-required
|